Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Information Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,773 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,607 · Balance 41,401 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,084 · Balance 42,485 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 1,995 · Balance 44,480 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,360 · Balance 45,840 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,067 · Balance 42,773 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,607 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,084 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,978 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 1,995 · Balance 7,978 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,162 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,360 · Balance 8,162 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,360 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · derivative · entry 9 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,162 Underlying: Common Stock · 1,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · derivative · entry 8 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,978 Underlying: Common Stock · 1,995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · derivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,067 | $174.75 | $535,958.25 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · nonDerivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,773 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 01:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000024 · wk-form4_1790974847.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 4,000 | $158.05 | $632,193.20 |
DisclosureSEC source: 0001927831-26-000022 · wk-form4_1789423900.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,794 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $157.99 to $158.215. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · derivative · entry 9 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,522 Underlying: Common Stock · 1,361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,994 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · derivative · entry 8 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,973 Underlying: Common Stock · 1,994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · derivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,084 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 3,066 | $170.77 | $523,580.82 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · nonDerivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,794 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000020 · wk-form4_1783030330.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000016 · wk-form4_1781734026.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 314 | $129.82 | $40,763.48 |
DisclosureSEC source: 0001927831-26-000016 · wk-form4_1781734026.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,414 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000016 · wk-form4_1781734026.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 30, 2026 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 600 | $131.08 | $78,648.00 |
DisclosureSEC source: 0001927831-26-000018 · wk-form4_1782855641.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,814 F1 · price: Based on the foregoing transactions, the Company identified recoverable Section 16(b) short-swing profits in the amount $192, which Mr. Kalia has paid to the Company. Read SEC document |
| June 15, 2026 Filed Jun 30, 2026 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | PurchaseCommon Stock | 600 | $130.76 | $78,456.00 |
DisclosureSEC source: 0001927831-26-000018 · wk-form4_1782855641.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,414 Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 22:09 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 3,418 | $130.24 | $445,155.53 |
DisclosureSEC source: 0001927831-26-000014 · wk-form4_1781561340.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,090 Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:27 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 5,000 | $130.41 | $652,030.00 |
DisclosureSEC source: 0001927831-26-000012 · wk-form4_1781296019.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,508 Read SEC document |
| June 10, 2026 Filed Jun 30, 2026 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 600 | $130.86 | $78,516.00 |
DisclosureSEC source: 0001927831-26-000018 · wk-form4_1782855641.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,814 Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 5,359 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · derivative · entry 9 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,883 Underlying: Common Stock · 5,359 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,994 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · derivative · entry 8 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,967 Underlying: Common Stock · 1,994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · derivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,168 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,214 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,092 | $91.15 | $464,135.80 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · nonDerivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,249 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · nonDerivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000010 · wk-form4_1775164975.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 637 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000008 · wk-form4_1773787717.xml · derivative · entry 5 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Common Stock · 637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 12,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000008 · wk-form4_1773787717.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 6,839 | $85.49 | $584,666.11 |
DisclosureSEC source: 0001927831-26-000008 · wk-form4_1773787717.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,297 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000008 · wk-form4_1773787717.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 12,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000008 · wk-form4_1773787717.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2026 Filed Mar 14, 2026 00:35 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 13,632 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000006 · wk-form4_1773448497.xml · derivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,632 Underlying: Common Stock · 13,632 shares Expires not disclosed F1 · derivative.exercise_date: This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 14 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,721 Underlying: Common Stock · 10,000 shares Expires 2034-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 13 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,410 Underlying: Common Stock · 10,000 shares Expires 2033-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a stock option award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 12 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,414 Underlying: Common Stock · 5,000 shares Expires 2033-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 9, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $74.00 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 11 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,670 Underlying: Common Stock · 1,000 shares Expires 2030-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a stock option award granted on April 20, 2020 that vests over a four-year period. 25% of the shares subject to such award vested on January 7, 2021 and the remaining 75% of the shares vested in equal monthly installments over the three-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $47.20 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 10 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,305 Underlying: Common Stock · 15,000 shares Expires 2032-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This represents a stock option award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,119 | $0.00 Strike: $47.20 | $0.00 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · derivative · entry 9 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,305 Underlying: Common Stock · 2,119 shares Expires 2032-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This represents a stock option award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 13,020 | $95.73 | $1,246,349.92 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 8 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,643 F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.46 to $96.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 26,980 | $95.12 | $2,566,310.62 |
DisclosureSEC source: 0001927831-26-000004 · wk-form4_1772750655.xml · nonDerivative · entry 7 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,663 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $94.460 to $95.455. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.